Baxter International Inc. (BAX) financial statements and ratios from SEC XBRL: revenue $11.24B (TTM), net margin -8.5%, revenue growth 5.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $11.24B |
| Net Margin | -8.5% |
| Return on Equity | -17.2% |
| Debt / Equity | 1.53 |
| Current Ratio | 1.95 |
| Revenue Growth (YoY) | 5.3% |
| EPS Growth (YoY) | 33.3% |
| EV / EBITDA | 16.8 |
| Price / Book | 2.21 |
| Price / Sales | 1.19 |
| Dividend Yield | 1.3% |
| DCF Value (model) | $17.64 |
| DCF Upside vs Price | -33.2% |
| Altman Z-Score | 2.28 (grey) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
BAX overview · BAX earnings · BAX KPIs · BAX investor relations · BAX ownership · BAX peers · BAX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.